Literature DB >> 25241719

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.

Rury R Holman1, Harald Sourij2, Robert M Califf3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25241719     DOI: 10.1016/S0140-6736(14)61674-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Resveratrol Attenuates High Glucose-Induced Vascular Endothelial Cell Injury by Activating the E2F3 Pathway.

Authors:  Xiaolian Ding; Wei Yao; Jie Zhu; Kaida Mu; Jing Zhang; Jin-An Zhang
Journal:  Biomed Res Int       Date:  2020-04-28       Impact factor: 3.411

2.  Work-loss years among people diagnosed with diabetes: a reappraisal from a life course perspective.

Authors:  Mikaela B von Bonsdorff; Monika E von Bonsdorff; Maija Haanpää; Minna Salonen; Tuija M Mikkola; Hannu Kautiainen; Johan G Eriksson
Journal:  Acta Diabetol       Date:  2018-02-17       Impact factor: 4.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.